Les Iminosucres : applications thérapeutiques actuelles et futures
Author:
- 1 January 2007
- journal article
- Published by Elsevier in Annales Pharmaceutiques Françaises
- Vol. 65 (1) , 5-13
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Design and Synthesis of Highly Potent and Selective Pharmacological Chaperones for the Treatment of Gaucher's diseaseChemBioChem, 2006
- Design and synthesis of iminosugar-based inhibitors of glucosylceramide synthase: the search for new therapeutic agents against Gaucher diseaseTetrahedron: Asymmetry, 2005
- Sustained therapeutic effects of oral miglustat (Zavesca, N‐butyldeoxynojirimycin, OGT 918) in type I Gaucher diseaseJournal of Inherited Metabolic Disease, 2004
- Effects of Interferon, Ribavirin, and Iminosugar Derivatives on Cells Persistently Infected with Noncytopathic Bovine Viral Diarrhea VirusAntimicrobial Agents and Chemotherapy, 2004
- A contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activityTrends in Pharmacological Sciences, 2003
- Small–molecule therapeutics for the treatment of glycolipid lysosomal storage disordersPhilosophical Transactions of the Royal Society B: Biological Sciences, 2003
- Structure-Activity Relationship of a New Class of Anti-Hepatitis B Virus AgentsAntimicrobial Agents and Chemotherapy, 2002
- In vitro inhibition and intracellular enhancement of lysosomal α‐galactosidase A activity in Fabry lymphoblasts by 1‐deoxygalactonojirimycin and its derivativesEuropean Journal of Biochemistry, 2000
- Molecular requirements of imino sugars for the selective control of N-linked glycosylation and glycosphingolipid biosynthesisTetrahedron: Asymmetry, 2000
- Characterization of a Mutant α-Galactosidase Gene Product for the Late-Onset Cardiac Form of Fabry DiseaseBiochemical and Biophysical Research Communications, 1993